Dr. Xie Fangmin remarked, “We are partnering with Novo Nordisk, a leading global healthcare company, to explore AI technology ...

Paris, France (21 July 2025) – EssilorLuxottica announces today it has signed an agreement with the South Korean company PUcore for the acquisition of all its assets and entities involved in the ...

Take D-Bal, for instance. Inspired by Dianabol, it uses a blend of MSM, Ashwagandha, L-Leucine, and Suma Root to increase ...

Bonatech, a company specialising in the application of membrane technology for the research and development of membrane materials and the manufacturing of membrane equipment, has announced the ...

With synthetic steroid use declining and clean performance on the rise, CrazyBulk has emerged as the trusted name in legal ...

The Anosh Inc Foundation is a nonprofit organization based in Chicago, focused on enhancing lives through programs in ...

ALK ( ALKB:DC / OMX: ALK B) today announced that the Medicines and Healthcare Products Regulatory Agency (MHRA) has approved EUR neffy® 2 mg in the United Kingdom (UK) for anaphylaxis treatment of ...

When paired with oral legal peptides focused on recovery and muscle support, this stack becomes a dual-threat system: fat ...

Interested investors and other parties may also listen to a simultaneous webcast of the conference call by logging onto the Investor Relations section of the Company's website at ...

Net Profit Achieved: Q2 2025 marked Hapbee’s first profitable quarter in company history, with net income of $17,988, compared to a net loss of $178,984 in Q1 2025 and a loss of $1.86 million in Q2 ...

Each option was granted pursuant to the Aardvark Therapeutics, Inc. 2025 Inducement Equity Incentive Plan, and was granted as an inducement material to each employee’s employment with Aardvark in ...

EURneffy is the trade name for neffy® (epinephrine nasal spray) in the United Kingdom. About neffy® neffy is a nasal spray used for emergency treatment of allergic reactions including anaphylaxis, in ...